Exparel 1.3% 20ML 10S
Ended Awarded
- Contract number
- SPE2DX25FKVVN
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $5,021
Award facts
- Contract value 100% obligated
- $5,021.26 Current and potential, with all options
- Completion date
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order award valued at $5,021.26 from the Defense Logistics Agency's Medical Supply Chain for EXPAREL 1.3% 20ML (10 units). This firm fixed-price delivery order, awarded on August 4, 2025, with an ultimate completion date of August 4, 2025, represents a single transaction under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The company holds a significant $499.999 billion single-award IDC under the SPE2DB program (valid through November 2026), which authorizes the agency to issue delivery orders for comprehensive pharmaceutical products supporting military health facilities worldwide. No set-aside designation was utilized for this award.
EXPAREL is a liposomal bupivacaine formulation commonly used in surgical and pain management settings. This delivery order exemplifies DMS Pharmaceutical Group's established role as a critical supplier within the federal pharmaceutical supply chain, providing direct distribution of specialty medications and medical consumables to Department of Defense healthcare sites. The vendor's federal contracting portfolio demonstrates consistent success in competing for pharmaceutical product deliveries without specific set-aside provisions, leveraging its status as a woman-owned small business to secure contracts across diverse medical product categories ranging from oncology treatments to injectable medications and specialty formulations.
Quick answers
Who was awarded contract SPE2DX25FKVVN?
SPE2DX25FKVVN was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on August 4, 2025.
How much is contract SPE2DX25FKVVN worth?
The government has obligated $5,021 on SPE2DX25FKVVN.
Is contract SPE2DX25FKVVN an order under another contract?
Yes. SPE2DX25FKVVN is a delivery order under SPE2DX15D9628, an indefinite delivery contract.
Was contract SPE2DX25FKVVN competed?
The extent of competition for SPE2DX25FKVVN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award